Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells

被引：31

作者：

Abken, Hinrich ^{[1
,2
]}

机构：

[1] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany

[2] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

来源：

HUMAN GENE THERAPY | 2017年 / 28卷 / 11期

关键词：

chimeric antigen receptor; adoptive cell therapy; T cell; solid tumor; CHIMERIC ANTIGEN RECEPTORS; I CLINICAL-TRIAL; PHASE-I; ANTITUMOR-ACTIVITY; CD28; COSTIMULATION; RECOMBINANT IMMUNORECEPTORS; ESTABLISHED TUMORS; IMMUNOTHERAPY; EFFICACY; RECOGNITION;

D O I：

10.1089/hum.2017.115

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Adoptive therapy with chimeric antigen receptor (CAR) redirected T cells achieved lasting remissions in hematologic malignancies, even in terminal stages of the disease. Exploring CAR T cell therapy in the treatment of solid tumors has just begun, balancing efficacy versus toxicity in early phase trials. In contrast to leukemia/lymphoma, solid tumors display a tremendously variable biology demanding different strategies to make a T cell attack successful in the long term. This article summarizes current developments, discusses the hurdles, and considers some modifications to improve the CAR T cell therapy in the treatment of solid tumors.

引用

页码：1047 / 1060

页数：14

共 92 条

[1] Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma [J].

Ahmed, Nabil ;

Brawley, Vita S. ;

Hegde, Meenakshi ;

Robertson, Catherine ;

Ghazi, Alexia ;

Gerken, Claudia ;

Liu, Enli ;

Dakhova, Olga ;

Ashoori, Aidin ;

Corder, Amanda ;

Gray, Tara ;

Wu, Meng-Fen ;

Liu, Hao ;

Hicks, John ;

Rainusso, Nino ;

Dotti, Gianpietro ;

Mei, Zhuyong ;

Grilley, Bambi ;

Gee, Adrian ;

Rooney, Cliona M. ;

Brenner, Malcolm K. ;

Heslop, Helen E. ;

Wels, Winfried S. ;

Wang, Lisa L. ;

Anderson, Peter ;

Gottschalk, Stephen .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) :1688-+

[2] Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA [J].

Bai, Yun ;

Kan, Shifeng ;

Zhou, Shixin ;

Wang, Yuting ;

Xu, Jun ;

Cooke, John P. ;

Wen, Jinhua ;

Deng, Hongkui .

CELL DISCOVERY, 2015, 1

[3] Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies [J].

Beatty, Gregory L. ;

Haas, Andrew R. ;

Maus, Marcela V. ;

Torigian, Drew A. ;

Soulen, Michael C. ;

Plesa, Gabriela ;

Chew, Anne ;

Zhao, Yangbing ;

Levine, Bruce L. ;

Albelda, Steven M. ;

Kalos, Michael ;

June, Carl H. .

CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :112-120

[4] Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer [J].

Birkholz, K. ;

Hombach, A. ;

Krug, C. ;

Reuter, S. ;

Kershaw, M. ;

Kaempgen, E. ;

Schuler, G. ;

Abken, H. ;

Schaft, N. ;

Doerrie, J. .

GENE THERAPY, 2009, 16 (05) :596-604

[5] Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy [J].

Brown, Christine E. ;

Alizadeh, Darya ;

Starr, Renate ;

Weng, Lihong ;

Wagner, Jamie R. ;

Naranjo, Araceli ;

Ostberg, Julie R. ;

Blanchard, M. Suzette ;

Kilpatrick, Julie ;

Simpson, Jennifer ;

Kurien, Anita ;

Priceman, Saul J. ;

Wang, Xiuli ;

Harshbarger, Todd L. ;

D'Apuzzo, Massimo ;

Ressler, Julie A. ;

Jensen, Michael C. ;

Barish, Michael E. ;

Chen, Mike ;

Portnow, Jana ;

Forman, Stephen J. ;

Badie, Behnam .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) :2561-2569

[6] Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma [J].

Brown, Christine E. ;

Badie, Behnam ;

Barish, Michael E. ;

Weng, Lihong ;

Ostberg, Julie R. ;

Chang, Wen-Chung ;

Naranjo, Araceli ;

Starr, Renate ;

Wagner, Jamie ;

Wright, Christine ;

Zhai, Yubo ;

Bading, James R. ;

Ressler, Julie A. ;

Portnow, Jana ;

D'Apuzzo, Massimo ;

Forman, Stephen J. ;

Jensen, Michael C. .

CLINICAL CANCER RESEARCH, 2015, 21 (18) :4062-4072

[7] Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy [J].

Buckanovich, Ronald J. ;

Facciabene, Andrea ;

Kim, Sarah ;

Benencia, Fabian ;

Sasaroli, Dimitra ;

Balint, Klara ;

Katsaros, Dionysios ;

O'Brien-Jenkins, Anne ;

Gimotty, Phyllis A. ;

Coukos, George .

NATURE MEDICINE, 2008, 14 (01) :28-36

[8] Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma [J].

Budde, Lihua E. ;

Berger, Carolina ;

Lin, Yukang ;

Wang, Jinjuan ;

Lin, Xubin ;

Frayo, Shani E. ;

Brouns, Shaunda A. ;

Spencer, David M. ;

Till, Brian G. ;

Jensen, Michael C. ;

Riddell, Stanley R. ;

Press, Oliver W. .

PLOS ONE, 2013, 8 (12)

[9] Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes [J].

Caruana, Ignazio ;

Savoldo, Barbara ;

Hoyos, Valentina ;

Weber, Gerrit ;

Liu, Hao ;

Kim, Eugene S. ;

Ittmann, Michael M. ;

Marchetti, Dario ;

Dotti, Gianpietro .

NATURE MEDICINE, 2015, 21 (05) :524-U158

[10] Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity [J].

Caruso, Hillary G. ;

Hurton, Lenka V. ;

Najjar, Amer ;

Rushworth, David ;

Ang, Sonny ;

Olivares, Simon ;

Mi, Tiejuan ;

Switzer, Kirsten ;

Singh, Harjeet ;

Huls, Helen ;

Lee, Dean A. ;

Heimberger, Amy B. ;

Champlin, Richard E. ;

Cooper, Laurence J. N. .

CANCER RESEARCH, 2015, 75 (17) :3505-3518

← 1 2 3 4 5 6 7 8 9 10 →